Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment

Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment

Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes

Hospital effluents as a source of emerging pollutants: An overview of micropollutants and sustainable treatment options

Analysis and removal of emerging contaminants in wastewater and drinking water

Development of a multi-residue analytical methodology based on liquid chromatography–tandem mass spectrometry (LC–MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters